“Four primary metabolites of bupropion, threo‐ and erythro‐hydrobupropion and R ,R‐ and S,S‐OH‐bupropion, circulate at higher concentrations than the parent drug and are believed to contribute to the efficacy and side effects of bupropion as well as to the CYP2D6 inhibition.”